Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000116304 | SCV000303921 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000710499 | SCV000840735 | benign | not provided | 2017-10-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000029317 | SCV001720460 | benign | Polyglandular autoimmune syndrome, type 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710499 | SCV001905005 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000710499 | SCV005276617 | benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029317 | SCV000051963 | benign | Polyglandular autoimmune syndrome, type 1 | 2010-11-20 | no assertion criteria provided | clinical testing | |
Genetic Services Laboratory, |
RCV000116304 | SCV000150222 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV000029317 | SCV001452104 | benign | Polyglandular autoimmune syndrome, type 1 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000116304 | SCV001743244 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000116304 | SCV001926954 | benign | not specified | no assertion criteria provided | clinical testing |